References
- ChandraratnaRASTazarotene-first of a new generation of receptor-selective retinoidsBritish Journal of Dermatology199613518259035701
- El-DomyatiMAttiaSSalehFIntrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skinExperimental Dermatology20021139840512366692
- HadshiewIMEllerMSGilchrestBASkin Aging and Photoaging: The Role of DNA Damage and RepairAmerican Journal of Contact Dermatitis200011192510684385
- KangSLeydenJLoweNJTazarotene cream for the treatment of facial photodamageArchives of Dermatology2001137159760411735710
- KangSBergfieldWGottliebABLong-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skinAmerican Journal of Clinical Dermatology200562455316060712
- KangSKruegerGGTanghettiEAA multicenter, randomised, double-blind trial of tazarotene 0.1% cream in the treatment of photodamageJournal of the American Academy of Dermatology2005522687415692472
- LoweNJGiffordMTanghettiETazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomised, parallel group studyJournal of Cosmetic and Laser Therapy20046798515203997
- LoweNHorwitzSTanghettiETazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicentre, double-blind, randomised studyJournal of Cosmetic Laser Therapy200681217
- MachtingerLAKaidbeyKLimJHistological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6 month, multicentre, double-blind, randomised, vehicle controlled study in patients with photodamaged facial skinBritish Journal of Dermatology200415112455215606521
- PhillipsTJGottliebABLeydenJLEfficacy of 0.1% tazarotene cream for the treatment of photodamageArchives of Dermatology200213814869312437455
- SamuelMBrookeRCHollisSInterventions for photodamaged skinCochrane Database of Systematic Reviews2005CD001782
- SeftonJKligmanAMKopperSCPhotodamage pilot study: A double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gelJournal of the American Academy of Dermatology2000436566311004622
- YaarMGilchrestBCellular and molecular mechanisms of cutaneous agingJournal of Dermatologic Surgery and Oncology199016915222229633